Sutro Biopharma Inc (STRO) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 32.25%9.84 | 14.52 | 11.65 | 9.69 | 63.75 |
10.08%39.73 | 44.18 | 49.70 | 58.15 | 67.09 | |
| Research and Development | 13.29%31.70 | 36.55 | 36.64 | 39.85 | 38.33 |
| Operating Income/Loss | 0.78%-29.89 | -29.66 | -38.05 | -48.46 | -3.35 |
| Income/Loss From Continuing Operations Before Tax | 0.09%-38.53 | -38.50 | -46.84 | -56.86 | -11.52 |
| Income Tax Expense/Benefit | 106.67%0.00 | -0.02 | -0.08 | - | -0.02 |
0.13%-38.53 | -38.48 | -46.76 | -56.86 | -11.50 | |
| Attributable To Parent | 0.13%-38.53 | -38.48 | -46.76 | -56.86 | -11.50 |
| Basic Average Shares | 26.67%16.57 | 13.08 | - | 84.87 | 84.58 |
| Diluted Average Shares | 26.67%16.57 | 13.08 | - | 84.87 | 84.58 |
| Basic Earnings Per Share | 20.75%-2.33 | -2.94 | - | -0.67 | -0.14 |
| Diluted Earnings Per Share | 20.75%-2.33 | -2.94 | - | -0.67 | -0.14 |